NCT04194437View on ClinicalTrials.gov

OCS Liver DCD Trial

NATerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

July 24, 2020

Primary Completion Date

March 22, 2022

Study Completion Date

December 16, 2024

Conditions
Liver Transplant
Interventions
DEVICE

OCS Liver System

The OCS Liver System will be used to preserve, optimize and assess livers from DCD donors.

Trial Locations (4)

10029

Mount Sinai Hospital, New York

48202

Henry Ford Hospital, Detroit

78249

University of Texas San Antonio, San Antonio

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

TransMedics
All Listed Sponsors
lead

TransMedics

INDUSTRY

NCT04194437 - OCS Liver DCD Trial | Biotech Hunter | Biotech Hunter